Moreno Evelyn V buys $6,762,014 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Moreno Evelyn V scooped up 1,670 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 20, 2016. The investment management firm now holds a total of 61,810 shares of Stryker Corporation which is valued at $6,762,014.Stryker Corporation makes up approximately 2.58% of Moreno Evelyn V’s portfolio.

Stryker Corporation opened for trading at $109.44 and hit $110.06 on the upside on Friday, eventually ending the session at $109.4, with a gain of 0.08% or 0.09 points. The heightened volatility saw the trading volume jump to 18,37,756 shares. Company has a market cap of $40,804 M.

Other Hedge Funds, Including , Cornerstone Advisors boosted its stake in SYK in the latest quarter, The investment management firm added 66 additional shares and now holds a total of 337 shares of Stryker Corporation which is valued at $36,868. Stryker Corporation makes up approx 0.04% of Cornerstone Advisors’s portfolio.Private Trust Co Na boosted its stake in SYK in the latest quarter, The investment management firm added 742 additional shares and now holds a total of 18,834 shares of Stryker Corporation which is valued at $2,060,440. Stryker Corporation makes up approx 0.55% of Private Trust Co Na’s portfolio.Private Bank Trust Co reduced its stake in SYK by selling 638 shares or 12.96% in the most recent quarter. The Hedge Fund company now holds 4,285 shares of SYK which is valued at $468,779. Stryker Corporation makes up approx 0.08% of Private Bank Trust Co’s portfolio.Gateway Investment Advisers reduced its stake in SYK by selling 10,581 shares or 32.0% in the most recent quarter. The Hedge Fund company now holds 22,480 shares of SYK which is valued at $2,459,312. Stryker Corporation makes up approx 0.02% of Gateway Investment Advisers’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.